HuagongsheHuagongshe Chemistry Print Report · For research reference only
Dopamine Hydrochloride → HCID 22976102, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Dopamine Hydrochloride | HCID 65340 | — |
| Reactant | N-((9H-Fluoren-9-ylmethoxy)carbonyl)-S-(triphenylmethyl)-L-cysteine | HCID 128239 | — |
| Reactant | HCID 22976136 | HCID 22976136 | — |
| Reactant | HCID 69566153 | HCID 69566153 | — |
| Product | HCID 22976102 | HCID 22976102 | — |
Reaction Steps
Commercially available Nα-(9-Fluorenylmethoxycarbonyl)-S-trityl-L-cysteine (1.7 g, 2.9 mmol) was coupled with dopamine hydrochloride (825 mg, 4.3 mmol) according to the indications of general procedure F. The crude N-[Nα-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteinyl]dopamine (618 mg, 0.86 mmol) was deprotected according to the indications of general procedure G. The resulting intermediate was then coupled with 2-fluorosalicylic acid (202 mg, 1.3 mmol) according to the indications of general procedure D. The final product was purified by flash chromatography using 99% CH2Cl2/1% AcOH and successively 5% then 10% AcOEt/CH2C2/1% AcOH to yield the desired derivative (260 mg, 48%) as white crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06528655B1 |
| Source dataset | uspto-grants-2003_03 |
| ORD ID | ord-595353852ea04cf69381da409468d959 |
| Source note | uspto-grants-2003_03 |